Compare · SERM
Enclomiphene vs Tamoxifen
Both are serm compounds. Here's how they line up on the evidence — graded the same way.
| Enclomiphene | Tamoxifen | |
|---|---|---|
| Evidence | 8/10 | 10/10 |
| Class | SERM | SERM |
| Summary | Enclomiphene is the anti-estrogenic isomer of clomiphene — a selective estrogen receptor modulator (SERM), not a peptide. Human trials consistently show it raises testosterone while preserving fertility, but it is NOT FDA-approved for any use, is available only via off-label compounding, and is banned in sport at all times. | Tamoxifen is a selective estrogen receptor modulator (SERM) — an FDA-approved breast-cancer drug with one of the strongest evidence bases in oncology, not a peptide. Anabolic-steroid users take it off-label to blunt gynecomastia and attempt testosterone 'restart,' an unstudied practice that is banned in sport (WADA S4.2) and not without real risk. |
| Full profile → | Full profile → |
Enclomiphene
Enclomiphene gets passed around fitness and "research chemical" circles as if it were a peptide or a sleek new-generation drug. It is neither. It is one of the two halves (isomers) that make up clomiphene — specifically the anti-estrogen half — and it is a small-molecule pill in a drug family…
Tamoxifen
Tamoxifen, sold as Nolvadex, is a selective estrogen receptor modulator (SERM — a drug that turns the estrogen signal up in some tissues and down in others). It is one of the most thoroughly studied drugs in all of cancer medicine. It helps to be clear about what it is and isn't: tamoxifen is not a…